Pfizer beats profit estimates on cost cuts, COVID vaccine sales
(Reuters) -Drugmaker Pfizer posted a better than expected fourth quarter profit on Thursday, helped by cost cuts and a smaller-than-feared drop in sales of its COVID-19 vaccine. "Our revenue volatility is largely in the past as COVID-related uncertainties have diminished,
Pfizer’s Covid boost overshadowed by Kennedy threat to vaccines
Pfizer shares, which had risen Tuesday morning after improved demand for the Covid vaccine, dropped 2.3% after Kennedy's nomination moved forward.
Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off
The results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its Covid business and stock price.
Pfizer shows profit growth from cost cuts and steadier COVID sales
By Bhanvi Satija, Michael Erman (Reuters) -Drugmaker Pfizer posted a better than expected fourth quarter profit on Thursday, helped by cost cuts it began last year as it aims to show investors steadier execution and growth after large swings related to its COVID-19 vaccine.
Pfizer gets unexpected boost from Covid vaccine and pill
Sales of the Covid vaccine and pill were around $550 million more than analysts had been expecting for the quarter. Pfizer investors are trying to figure out what the “new normal” will be for those products as interest in treating the virus fades with time.
KMOV St. Louis on MSN36m
Nasal COVID vaccine developed at WashU approved for clinical trials
The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...
McKnight's Long-Term Care News10h
‘Vaccine fatigue’ could be a common LTC theme in 2025
Many nursing home residents are refusing COVID shots this winter, though flu vaccine penetration has remained strong historically.
Nasal COVID-19 vaccine to enter US clinical trials
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 ...
Michigan flu, RSV, COVID surges wreak 'havoc' in Corewell emergency departments
Michigan's largest health system urges patients to seek nonemergency care at sites other than its ERs amid a surge in flu, ...
Trump's reinstatement of troops booted over COVID vaccine hailed as win for freedom: 'Great day for patriots'
Fla., praised news that President Donald Trump will reinstate service members expelled for refusing to take the COVID-19 ...
Time on MSN7d
RFK Jr. Says He Doesn’t Know if COVID-19 Vaccines Work
R obert F. Kennedy Jr., President Trump’s pick to head the U.S. Department of Health and Human Services (HHS), was grilled by ...
CNN on MSN13d
NIH interim director comes from its research ranks but is known for questioning Covid-19 vaccine mandates
Dr. Matthew Memoli, a National Institute of Allergy and Infectious Diseases researcher focused on flu and other respiratory ...
La Crosse Tribune6d
Development of an mRNA vaccine for Covid-19 was fast
Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...
thecardiologyadvisor.com3d
COVID-19 Vaccine Confers Protection Against Post-COVID-19 Conditions
The COVID-19 vaccine confers protection against the development of post-COVID-19 conditions, particularly during the Delta and Omicron eras.
EurekAlert!2d
Nasal COVID-19 vaccine based on WashU technology to enter US clinical trials
A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...
WBBM Radio Chicago on MSN5h
Mayor’s office rescinds COVID-19 vaccine mandate, ‘2 years too late’: police union president
The Fraternal Order of Police has been fighting the requirement since the Lightfoot administration imposed it in 2021.